In a 340-eye cohort, a sinusoidal pupil-adaptive IOL was associated with better intermediate and near vision, but lens allocation was not randomized.
doi: 10.1186/s12886-026-05426-zIn a single-center trial, Clareon T2 reduced residual cylinder and improved uncorrected vision, but did not change contrast performance at three months.
doi: 10.3389/fopht.2026.1755069In 85 patients, Vivity provided better uncorrected near and intermediate vision, whereas PureSee produced higher contrast sensitivity and less dysphotopsia.
doi: 10.1111/aos.70076In a randomized masked study, 40 patients received DEN00V in one eye and AN6V in the fellow eye. Both provided extended vision at three months, while the primary endpoint favored AN6V.
doi: 10.1016/j.ajo.2026.04.014In 92 patients, three EDOF approaches improved uncorrected intermediate and near vision compared with a monofocal lens, while the profile of photic phenomena differed between designs.
doi: 10.1016/j.jfo.2026.104823A randomized study of 70 cataract patients compared PanOptix with Vivity. Stereopsis favored the EDOF group at one month, while contrast sensitivity did not differ significantly between groups.
doi: 10.4103/IJO.IJO_2015_25